ABBOTT LABORATORIES

ABBOTT LABORATORIES
World Rank (Sep-01-2021)
48
Market Cap (Sep-01-2021)
224.030 Billion USD
World Rank (Jan-01-2021)
49
Market Value (Jan-01-2021)
194.060 Billion USD
World Rank (Jan-2020)
57
Market Value (Jan 1st 2020)
151.937 Billion USD
World Rank (July-04-2020)
55
Market Cap (July-04-2020):
163.141 Billion USD
World Rank (Aug-22-2020):
48
Market Cap (Aug-22-2020)
181.302 Billion USD
Annual Revenue in USD
34,600 Million USD
Annual Results for Year Ending
Dec-2020
Annual Net Income in USD
4,490 Million USD
Stock Category
S&P 500
Headquarters Region
Illinois
Headquarters Country
USA
Headquarters Continent
Americas
World Sub Region
Northern America
Rank in Country (Jan-2020)
Rank in USA in 2020 is 35
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 32
Company Business
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Technology
Medical Equipment
Number of Employees
107,000
Employee Count as on Date
As on 2019
CEO:
Robert Ford
Founders
Wallace Calvin Abbott
Founded Year
1888
Stock Exchange
NYSE
Switzerland
Yahoo @ NYSE
Wikipedia
Twitter
Facebook
Bloomberg
Company Website:
Abbott - Healthcare and Pharmaceutical Company
Business Sector:
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
Annual Revenue
ABBOTT LABORATORIES Annual Revenues for December-2020 ending is 34.60 Billion USD
Annual Operating Income
5.35 Billion USD for Year ending December-2020
Annual Net Income
ABBOTT LABORATORIES Annual Net Income for December-2020 ending is 4.49 Billion USD
Total Current Assets
ABBOTT LABORATORIES Total Current Assets as on June-2020 is 17,221 Million USD
Total Assets
ABBOTT LABORATORIES Total Assets as on June-2020 is 68,776 Million USD
Total Current Liabilities
ABBOTT LABORATORIES Total Current Liabilities as on June-2020 is 10,959 Million USD
Total Liabilities
ABBOTT LABORATORIES Total Liabilities as on June-2020 is 38,198 Million USD
Total Equity
ABBOTT LABORATORIES Total Equity as on June-2020 is 30,578 Million USD
About Company Business:

Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 107,000 employees as on 2019. Headquarters is in USA.

Annual Results Summary:

Abbott Laboratories - Yearly Revenue and Net Profit - in Million USD:

Year - Ending Revenue Net Profit EPS (USD)
Dec-2020 34,608 4,495  
Dec-2019 31,904 3,687 2.06
Dec-2018 30,578 2,368 1.35
Dec-2017 27,390   477 0.27
Dec-2016 20,853 1,400 0.95

 

Balance Sheet Summary

Abbott Laboratories - Balance Sheet Summary - in Million USD:

Year Ending: Total Current Assets Total Assets Total Current Liabilities Total Liabilities Total Equity
Dec-2020 20,441 72,548 11,907 39,764 32,784
Dec-2019 15,667 67,887 10,863 36,799 31,088
Dec-2018 14,632 67,173 9,012 36,649 30,524
Dec-2017 20,147 76,250 8,912 45,353 30,897
Dec-2016 26,776 52,666 6,660 32,128 20,538
Quarterly Results Summary:

Abbott Laboratories - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending Revenue Net Profit EPS (USD)
Sep-2021 10,928 2,100 1.18
Jun-2021 10,223 1,189 1.40
Mar-2021 10,456 1,793 1.17
Dec-2020 10,701 2,162 1.32
Sep-2020 8,853 1,232 0.98
Jun-2020 7,328 537 0.30
Mar-2020 7,726 564 0.32
Dec-2019 8,314 1,049 0.60
Sep-2019 8,076 960 0.54
Jun-2019 7,979 1,006 0.56
Mar-2019 7,535 672 0.38
Dec-2018 7,765 654 0.37
Sep-2018 7,656 563 0.32

Share it on Social Media